18 diciembre 2014
A family of molecules known as NTS enzyme inhibitors are promising candidates for new herpes virus treatments, a new study shows. The findings could lead to new treatment options for herpes that patients can use in conjunction with or instead of currently approved anti-viral medications like Acyclovir. Researchers likened a combination of treatments for herpes to a cocktail of medications HIV patients take.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/p4YxflXUcts/141218131937.htm
